Vlasveld L T, Beynen J H, Boogerd W, Ten Bokkel Huinink W W, Rodenhuis S
Clinical Research Unit, Netherlands Cancer Institute, Amsterdam.
Cancer Chemother Pharmacol. 1990;25(5):382-3. doi: 10.1007/BF00686244.
Brain metastases developed in a 40-year-old woman with relapsed ovarian cancer 2 years after cisplatin-based combination chemotherapy. After a single dose of 800 mg/m2 carboplatin, complete remission of the brain metastases occurred. A pharmacokinetic study during the second course revealed low levels of carboplatin in the cerebrospinal fluid.